D6B01E0AA51743A34C45117B2A5B950F7E3D2F72CC6F7562D19DA0B5E84BF1035B67478C68B8AD9BD0C7E9B10760F589

Occurs in 2 forms which differ in the post-translational modification of Val-6. In the form conophan gld-V, Val-6 is D-valine. In the form gamma-hydroxyconophan gld-V*, Val-6 is D-4-hydroxyvaline. Both diastereomeric forms of D-hydroxyvaline may be produced.

Source:http://purl.uniprot.org/SHA-384/D6B01E0AA51743A34C45117B2A5B950F7E3D2F72CC6F7562D19DA0B5E84BF1035B67478C68B8AD9BD0C7E9B10760F589

Statements in which the resource exists.
SubjectPredicateObjectContext
http://purl.uniprot.org/SHA...rdf:typeuniprot:PTM_Annotationlld:uniprot
http://purl.uniprot.org/SHA...rdfs:commentOccurs in 2 forms which differ in the post-translational modification of Val-6. In the form conophan gld-V, Val-6 is D-valine. In the form gamma-hydroxyconophan gld-V*, Val-6 is D-4-hydroxyvaline. Both diastereomeric forms of D-hydroxyvaline may be produced.lld:uniprot
uniprot-protein:P84700uniprot:annotationhttp://purl.uniprot.org/SHA...lld:uniprot